• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PER

PERCHERON THERAPEUTICS LIMITED

0.00% ! 1.0¢
Market Cap $10.87M  !

Percheron Therapeutics Limited, formerly Antisense Therapeutics Limited, is a... Percheron Therapeutics Limited, formerly Antisense Therapeutics Limited, is a biotechnology company. The Company is engaged in developing and commercializing antisense pharmaceuticals for large unmet markets in rare diseases. The Company’s products include ATL1102 for Duchenne muscular dystrophy (DMD), ATL1103 for Acromegaly, and ATL1102 for Multiple Sclerosis (MS). ATL1102, is an antisense inhibitor targeting very late antigen 4 (VLA-4), an immune cell molecule. ATL1103 is a second-generation antisense drug designed to block growth hormone receptor (GHr) expression thereby reducing levels of the hormone insulin-like growth factor-I (IGF-I) in the blood and is a potential treatment for diseases associated with excessive growth hormone action. By inhibiting GHr production, ATL1103 in turn reduces IGF-I levels in the blood (serum). The Company is conducting a Phase II clinical trial of ATL1102 in DMD patients.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
PER 15:49 15 3.2K
15:49 Last post  joe76 Comments Created with Sketch.  15  Views Created with Sketch.  3.2K 
PER 06/06/25 46 16K
06/06/25 Last post  RYNZN Comments Created with Sketch.  46  Views Created with Sketch.  16K 
PER 20/05/25 0 333
TRENDING NEWS

Gold, Brent Crude spike as Israel strikes Iran in worst-case scenario

NEWS
13 Jun 2025
20/05/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  333 
PER 20/05/25 0 297
20/05/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  297 
PER 14/05/25 0 342
14/05/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  342 
PER 14/05/25 0 436
14/05/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  436 
PER 07/05/25 0 353
07/05/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  353 
PER 06/05/25 18 6.4K
06/05/25 Last post  bajachris88 Comments Created with Sketch.  18  Views Created with Sketch.  6.4K 

See All Discussions arrow Created with Sketch.

Timeline

Change of Director's Interest Notice - Dr James Garner
20 May 10:33
 
Change of Directors Interest Notice - Dr Charmaine Gittleson
20 May 10:31
 
Notification regarding unquoted securities - PER
20 May 10:29
 
Letter to ineligible shareholders
14 May 08:19
 
Letter to eligible shareholders
14 May 08:19
 
Proposed issue of securities - PER
07 May 08:32
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
1.0¢
Change
0.000(0.00%)
Mkt cap ! $10.87M
Open High Low Value Volume
1.0¢ 1.0¢ 1.0¢ $71.80K 7.180M

Buyers (Bids)

No. Vol. Price($)
1 4649246 1.0¢
 

Sellers (Offers)

Price($) Vol. No.
1.1¢ 2600000 2
View Market Depth
Last trade - 15.21pm 13/06/2025 (20 minute delay) ?
Last
1.0¢
  Change
0.000 ( 0.00 %)
Open High Low Volume
1.0¢ 1.0¢ 1.0¢ 924500
Last updated 15.21pm 13/06/2025 ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.